The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The Department of Urology in AIIMS Bhopal successfully treated 13 hormonally active adrenal tumors in the past year using advanced laparoscopic techniques, demonstrating the institution's innovation ...

genetic condition called extra-adrenal pheochromocytoma or paraganglioma. It meant his body produced adrenaline secreting tumors that created a cardiac scare. Potts would have episodes where it ...

A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...

Second, because of widespread use of anatomic imaging studies, adrenal incidentalomas have become an important clinical entity for which pheochromocytoma must be considered, regardless of signs ...

Kanellis took to Twitter/X on September 3rd to provide an update. She wrote that they thought it was a pheochromocytoma, which meant that she had to take medication before the surgery so that she ...

scanning showed increased focal 131I activity that was consistent with right adrenal pheochromocytoma. The patient was advised to undergo surgical removal of the tumor but she refused, and surgery ...

Positron emission tomograph (coronal view) after intravenous injection of 6-[18 F]fluorodopamine. The patient had a small left adrenal pheochromocytoma. Approximately 6 months after removal of the ...